| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
83,436 |
70,465 |
$2.96M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
34,215 |
31,736 |
$1.33M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
78,092 |
36,465 |
$1.05M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,539 |
7,443 |
$589K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,604 |
11,249 |
$577K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,378 |
7,258 |
$544K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
38,801 |
36,390 |
$523K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,759 |
5,642 |
$473K |
| 94010 |
|
20,329 |
18,849 |
$466K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
27,966 |
14,490 |
$299K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,492 |
3,417 |
$253K |
| 99000 |
|
12,087 |
11,506 |
$125K |
| 80053 |
Comprehensive metabolic panel |
13,020 |
12,559 |
$113K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,205 |
14,456 |
$97K |
| 87807 |
|
8,563 |
7,900 |
$92K |
| 92587 |
|
5,635 |
5,547 |
$87K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,519 |
6,274 |
$68K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
780 |
773 |
$65K |
| 99381 |
|
671 |
663 |
$52K |
| 99383 |
|
596 |
587 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
781 |
774 |
$46K |
| 94760 |
|
17,900 |
15,326 |
$34K |
| 90461 |
|
4,086 |
3,191 |
$31K |
| 99382 |
|
278 |
278 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,689 |
1,613 |
$21K |
| 99051 |
|
4,453 |
4,127 |
$20K |
| 99384 |
|
210 |
209 |
$19K |
| 86308 |
|
4,150 |
4,085 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,215 |
1,180 |
$16K |
| 83655 |
|
1,375 |
1,359 |
$14K |
| 96161 |
|
6,459 |
6,381 |
$13K |
| 81003 |
|
7,077 |
6,843 |
$13K |
| 90474 |
|
1,112 |
1,093 |
$10K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
534 |
527 |
$7K |
| 17110 |
|
41 |
37 |
$4K |
| 69209 |
|
297 |
291 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
279 |
272 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
76 |
75 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
81 |
79 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,065 |
1,016 |
$2K |
| 86580 |
|
199 |
198 |
$2K |
| 69210 |
|
47 |
47 |
$1K |
| 93000 |
|
45 |
43 |
$524.06 |
| 97169 |
|
21 |
19 |
$330.00 |
| 97170 |
|
28 |
28 |
$300.00 |
| 90651 |
|
2,061 |
2,039 |
$190.29 |
| 81025 |
|
12 |
12 |
$86.76 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
17,083 |
16,834 |
$55.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
251 |
237 |
$30.74 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
17,095 |
16,833 |
$15.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
274 |
267 |
$11.54 |
| 90686 |
|
3,896 |
3,869 |
$2.59 |
| 90671 |
|
923 |
902 |
$1.32 |
| 90621 |
|
1,444 |
1,431 |
$0.40 |
| 90620 |
|
177 |
177 |
$0.28 |
| 90633 |
|
1,968 |
1,942 |
$0.00 |
| 90734 |
|
1,655 |
1,641 |
$0.00 |
| 90648 |
|
1,866 |
1,848 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
467 |
465 |
$0.00 |
| 90670 |
|
2,150 |
2,138 |
$0.00 |
| 90710 |
|
1,858 |
1,836 |
$0.00 |
| 90707 |
|
78 |
77 |
$0.00 |
| 90715 |
|
1,171 |
1,155 |
$0.00 |
| 90700 |
|
919 |
906 |
$0.00 |
| 90681 |
|
306 |
297 |
$0.00 |
| 90713 |
|
14 |
14 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
65 |
63 |
$0.00 |
| 90696 |
|
995 |
983 |
$0.00 |
| 90680 |
|
1,232 |
1,222 |
$0.00 |
| 90697 |
|
1,126 |
1,104 |
$0.00 |
| 90744 |
|
18 |
18 |
$0.00 |
| 90723 |
|
1,161 |
1,157 |
$0.00 |
| 90619 |
|
329 |
327 |
$0.00 |
| 90674 |
|
49 |
49 |
$0.00 |
| 90716 |
|
83 |
82 |
$0.00 |